SURMOUNT-2: Tirzepatide Treatment Leads to Average 15% Weight Loss in Adults with …

Weightloss News
Among adults with type 2 diabetes (T2D) and obesity, treatment with tirzepatide was associated with an average weight loss of 15.7% over 72 weeks …